Currently Used Biologic Agents in the Management of Behcet’s Syndrome
Journal:
Current Medicinal Chemistry
Volume:
22
Page:
1976-1985
Author(s):
Caner Saygin, Didem Uzunaslan and Gulen Hatemi
Current Developments in Therapeutic and Diagnostic Strategies for Q Fever: Glimpses of Patent Analysis
Journal:
Recent Patents on Anti-Infective Drug Discovery
Volume:
9
Page:
104-111
Author(s):
Rashi Chauhan, Gulshan Wadhwa, Sanjeev K. Sharma and Chakresh K. Jain
The Intracellular Domain of Amyloid Precursor Protein is a Potential Therapeutic Target in Alzheimer’s Disease
Journal:
Current Drug Discovery Technologies
Volume:
11
Page:
243-258
Author(s):
Hisashi Nagase and Kohzo Nakayama
4Aβ1-15-Derived Monoclonal Antibody Reduces More Aβ Burdens and Neuroinflammation than Homologous Vaccine in APP/PS1 Mice
Journal:
Current Alzheimer Research
Volume:
12
Page:
384-397
Author(s):
Yuwei Zhang, Juntao Zou, Junhua Yang and Zhibin Yao
New Developments of Clinical Trial in Immunotherapy for Alzheimer's Disease
Journal:
Current Pharmaceutical Biotechnology
Volume:
16
Page:
484-491
Author(s):
Cece Yang and Shifu Xiao
Vanutide Cridificar and the QS-21 Adjuvant in Japanese Subjects with Mild to Moderate Alzheimer’ s Disease: Results from Two Phase 2 Studies
Journal:
Current Alzheimer Research
Volume:
12
Page:
242-254
Author(s):
Heii Arai, Hideo Suzuki and Tamotsu Yoshiyama
Non-Classical Therapeutic Approach in the Treatment of Alzheimer's Disease: A Mini Review
Journal:
Letters in Drug Design & Discovery
Volume:
12
Page:
158-164
Author(s):
Vladan Bajic, Biljana Spremo-Potparevic, Lada Zivkovic, Emina Sudar, Sonja Zafirovic, Milan Obradovic and Esma R. Isenovic
Intravenous Immunoglobulins for Alzheimer's Disease
Journal:
Current Alzheimer Research
Volume:
11
Page:
626-636
Author(s):
Lakshman Puli, Heikki Tanila and Norman Relkin
Bacteriophage - A Common Divergent Therapeutic Approach for Alzheimer's Disease and Type II Diabetes Mellitus
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
13
Page:
491-500
Author(s):
Sayed S. Sohrab, Sajjad Karim, Mohammad A. Kamal, Adel M. Abuzenadah, Adeel G. Chaudhary, Mohammed H. Al-Qahtani and Zeenat Mirza
The Effects of Soluble Aβ Oligomers on Neurodegeneration in Alzheimer's Disease
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2506-2519
Author(s):
Jonathan Brouillette